Listen to our debrief of The Health Management Academy's Spring 2026 Chief Supply Chain Officer (CSCO) Forum. In our debrief, we shared what these executives discussed with their peers, including what CSCOs are working on right now.
Below are key takeaways for what is top of mind for CSCOs and what you need to know going into your next conversation with them:
Data Readiness Is the Real Bottleneck on AI. Despite high personal enthusiasm for AI, SCOs consistently identify fragmented and inaccurate data — not the technology — as the binding constraint, with leaders cautioning that tools deployed without clean infrastructure risk producing unreliable output or automating the wrong processes entirely. Investment cases are also facing greater scrutiny, with soft ROI narratives giving way to a growing expectation of quantifiable hard-dollar returns.
Supply Chain Is Repositioning from Cost Center to Strategic Asset. Some leaders are actively expanding supply chain's span of control into non-traditional domains like construction and real estate, reframing the function as a revenue contributor and growth differentiator rather than a cost manager. Earning recognition for that expanded role requires telling stories centered on what clinical and operational leaders care about — outcomes, patient experience, and performance — not supply chain's traditional lens of cost and efficiency.
Talent Strategy Is Pivoting from Hiring to Cultivating. The talent gap has shifted from finding experienced operators to finding people capable of work that has never been done before, with leaders prioritizing critical thinkers who can engage the C-suite over analysts who build tables. Internal pipelines — fellowships, academies, and structured upskilling tracks — are emerging alongside funded education programs that have demonstrated measurable retention gains.
The COO-Supply Chain Partnership Is Where Strategic Credibility Gets Built. Supply chain's expanding mandate depends less on organizational structure than on the quality of its relationships with operations and clinical leadership — and leaders who invested early in data infrastructure and cross-functional trust report the strongest strategic positioning. Centralization for its own sake, however, can be counterproductive: the test should be whether consolidation genuinely improves cost, quality, or outcomes — not whether it grows supply chain's portfolio.
Integration Is Cultural Work That Takes Years, Not a Transaction That Closes in Months. Successful M&A integration is fundamentally a relational process, with some partnerships taking up to seven years before an acquired organization was ready to move fully forward — and post-close realities that frequently diverge from what due diligence reveals. Active relationship investment must continue well beyond initial stabilization, as cases of regression demonstrate that complacency years into an integration can undo hard-won progress.